Home›Companies›Biotech & Pharma›OncoXome

OncoXome, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 13, 2023·Suggest an edit

About OncoXome

OncoXome is a private company based in North Hollywood, California, incorporated in 2021 in Delaware. It has reported $170,500 raised in one offering on Form D since February 2023. Its chief executive is Erick Gamelin.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 2, 2022Feb 13, 2023$170,500of $1.0M target2$85,250Debt, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OncoXome's Form D filed Feb 13, 2023.

AG
Auriane Gamelin
Executive officer and director
LG
Laurence Gamelin
Executive officer and director
EG
Erick Gamelin
CEO and director

Sources

  1. SECOncoXome, Inc. filing history